Back to Search
Start Over
Approval in Japan of New Formulation of Mitsubishi Tanabe Pharma's Edaravone Will Further Bolster its Position as the Top-Selling Therapy for Acute Ischemic Stroke
- Source :
- PR Newswire. February 18, 2010
- Publication Year :
- 2010
-
Abstract
- Development of Novel Neuroprotective and Neurorestorative Therapies Continues to Advance, According to New Findings from Decision Resources WALTHAM, Mass., Feb. 18 /PRNewswire/ -- Decision Resources, one of the world's leading [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PR Newswire
- Publication Type :
- News
- Accession number :
- edsgcl.219129035